Physician profile
Sergio Bartakian
NPI 1801001771
$1,620.00
in general payments reported to CMS, 2019-2025
7 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $67.42 · 2021: $342 · 2022: $441 · 2023: $250 · 2024: $14.60 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $375 · Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $375.00 |
| Food and Beverage | $292.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $912.84 | 2019-2023 | Amplatzer Piccolo, Amplatzer |
| Renata Medical, INC. | $375.00 | 2025 | Minima Stent System - 6mm, Minima Stent System - 8mm |
| Medtronic, INC. | $162.22 | 2021 | |
| Penumbra, INC. | $74.08 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.23 | 2024-2025 | Lifevest |
| Edwards Lifesciences Corporation | $41.10 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Bartakian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.